Contrast Enhanced Digital Mammography Trends and Forecast
The future of the global contrast enhanced digital mammography market looks promising with opportunities in the screening and diagnosis markets. The global contrast enhanced digital mammography market is expected to reach an estimated $0.8 billion by 2030 with a CAGR of 10.6% from 2024 to 2030. The major drivers for this market are rising cases of breast cancer, increasing awarness about breast cancer, and introduction of software in mammography equipment.
• Lucintel forecasts that, within the technique category, technique dual energy CEDM will remain the largest segment over the forecast period.
• With the end use category, Diagnosis will remain a larger segment because it is used to evaluate the abnormalities detected during the process of screening in the area of concern.
• In terms of region North America will remain the largest region over the forecast period.
Gain valuable insights for your business decisions with our comprehensive 150+ page report.
Emerging Trends in the Contrast Enhanced Digital Mammography Market
The contrast-enhanced digital mammography (CEDM) market is experiencing significant changes due to advancements in technology and clinical practices. Emerging trends are shaping the future of breast imaging.
• AI and Machine Learning Integration: AI and machine learning are increasingly being incorporated into CEDM systems to improve image analysis and diagnostic accuracy. This integration assists in detecting subtle abnormalities, thus improving early tumor detection rates. AI algorithms help decrease false positives and negatives, resulting in more accurate diagnoses and streamlined radiologist workflows.
• Enhanced Image Resolution and Quality: Advances in image resolution and quality have improved the efficacy of CEDM. High-resolution imaging systems offer distinct, detailed images that aid in tumor detection, characterization, and staging. Improved image quality enhances the visualization of small or complex lesions, thereby leading to better diagnoses.
• Increased Adoption in Routine Screening: There has been an increase in the use of CEDM in routine breast cancer screening programs. Its improved ability to differentiate between tumors with better contrast is significant. This rise has been driven by evidence showing improvements in diagnostic accuracy and a demand for more effective screening methods.
• Development of Portable and Cost-Effective Solutions: The portable aspect of CEDM is becoming increasingly important, as it provides access to advanced imaging. Portable systems can be used in various healthcare settings, including remote and underserved areas. CEDM becomes more affordable through innovations that make the technique accessible to a broader population.
• Personalized Screening Protocols: Personalized screening models based on individual risk factors and genetic profiling are being introduced. These personalized screening strategies, alongside CEDM, customize diagnostic approaches for patients. This development improves the efficiency of screening programs and increases early detection rates.
• Integration with Other Imaging Modalities: There is a growing trend towards integrating CEDM with other imaging modalities, such as ultrasound or MRI, providing comprehensive diagnostic information. Combining CEDM with other imaging techniques enhances overall diagnostic accuracy and enables thorough evaluation of breast tissue.
• Advancements in Contrast Agents: Innovations aimed at improving contrast agents used in CEDM are enhancing its imaging performance. Newer contrast agents allow for better visualization of tumors with fewer side effects. Improvements in contrast technologies increase the diagnostic capabilities of CEDM, ensuring accurate and reliable results.
The CEDM market is being transformed by developing trends such as AI integration, improved image quality, and portable solutions. These developments enhance diagnostic accuracy, extend advanced imaging to more patients, and facilitate personalized and integrated breast cancer screening programs.
Recent Developments in the Contrast Enhanced Digital Mammography Market
Changes have taken place in contrast-enhanced digital mammography (CEDM) that are redefining how breast cancer is detected. Key events reflect technological improvements and adoption across different markets.
• Advancement in AI-Powered CEDM Systems: Diagnostic accuracy has improved through AI-powered CEDM systems that automatically analyze images for subtle abnormalities. Detection rates are enhanced with AI integration, reducing false positives and making it an effective tool for the early detection of breast cancer using CEDM technology.
• Introduction of High-Resolution Imaging Technologies: New high-resolution CEDM systems provide better visualization of small tumors and dense breasts due to their superior image quality. Improved resolution supports accurate diagnoses, resulting in better outcomes and accounting for the increasing adoption levels within clinical environments.
• Expansion of CEDM in Screening Programs: The increased uptake of CEDM in screening programs for breast cancer is due to its ability to offer clearer images while also providing greater tumor contrast. Clinical evidence indicates that its use improves diagnostic accuracy compared to traditional mammography, justifying its inclusion in screening programs.
• Portable CEDM Devices Development: Portable CEDM devices are being manufactured to expand access to advanced breast imaging in various healthcare settings. These devices facilitate remote deployment in underserved areas, thereby increasing reach and supporting the global screening initiative for breast cancer.
• Personalization of Screening Protocols: Personalized screening protocols using CEDM are becoming increasingly common. Such protocols tailor screenings based on individual risk factors, genetic profiles, and personal medical histories, leading to better early detection and targeted diagnostic approaches.
• Integration with Other Imaging Techniques: To allow for a holistic diagnosis, CEDM is being combined with other imaging modalities such as ultrasound and MRI. This integration enhances overall diagnostic accuracy and improves the evaluation and management of breast cancer.
• Advancements in Contrast Agent Technology: Newer contrast agents used in CEDM have enhanced imaging effectiveness. Recent advancements offer superior visualization of tumors with minimal side effects, resulting in more precise diagnoses that improve the performance of overall CEDM systems.
The evolution of CEDM technology is currently driven by recent developments, including advancements in artificial intelligence, high-resolution imagery, and portable devices. These innovations enhance diagnostic accuracy, broaden access to cutting-edge imaging technologies, and support more customized and effective strategies aimed at detecting breast cancer.
Strategic Growth Opportunities for Contrast Enhanced Digital Mammography Market
The market for CEDM contains strategic growth opportunities due to technological improvements and changing healthcare needs. Additionally, there are several key application areas for expansion and improvement.
• Expansion of AI Integration in CEDM Systems: The expansion of AI integration within CEDM systems presents an important opportunity for growth. This means that through AI, there is improved image analysis, thereby reducing diagnostic errors and increasing the early detection rate. Investing in artificial intelligence supports clearer diagnoses, smooths out radiology workflows, and makes it a worthwhile venture for market development.
• Development of Portable CEDM Systems: The development of portable CEDM systems has the potential for growth by enhancing access to advanced breast imaging. These mobile solutions can be deployed flexibly in remote or underserved regions, thus supporting wider screening campaigns and addressing global health inequalities.
• Personalized Screening Approaches with CEDM: Personalized screening approaches using CEDM enable diagnosis strategies based on risk profiles, leading to growth opportunities. Personalization is important as it helps detect diseases at their earliest stages, improving patient outcomes and creating increased demand for high-level imaging technologies.
• Advancement in Contrast Agent Technology for CEDM: The advancement in contrast agent technology for CEDM gives rise to growth potential by enhancing imaging performance and improving patient comfort. Improved tumor visualizations and reduced side effects caused by new contrast agents enhance diagnostic accuracy, promoting the use of CEDM elsewhere.
• Integration with Complementary Imaging Modalities: To create growth opportunities, CEDM can be harmonized with other imaging modalities like MRI and ultrasound to offer comprehensive diagnostic solutions. This unification enhances overall diagnostic accuracy and better assesses breast tissue types, facilitating market expansion.
The CEDM industry is determined by factors such as AI integration, portable systems, and personalized screening approaches that generate opportunities for growth. By adopting these possibilities, it will increase the effectiveness of diagnosis, expand access to advanced imaging techniques, and support better methods for detecting breast cancer.
Contrast Enhanced Digital Mammography Market Driver and Challenges
Several drivers and challenges affect the growth of the contrast-enhanced digital mammography (CEDM) market. The main determinants are technological advancements, economic considerations, and regulatory issues.
The factors responsible for driving the contrast-enhanced digital mammography market include:
• Technological Advancements: Technological advancements, such as high-resolution imaging and AI integration, drive market growth by enhancing diagnostic accuracy and efficiency. Innovations in CEDM systems help detect early tumors, leading to more accurate diagnoses.
• Growing Emphasis on Early Detection: Advanced imaging technologies, such as CEDM, are needed in response to the growing demand for early detection of breast cancer. Early detection yields successful treatment outcomes, resulting in higher use of improved diagnostic tools that contribute to market expansion.
• Government Initiatives and Funding: To expand the market, government initiatives and funding are directed towards breast cancer research and better diagnostics. Investments in CEDM technology and screening programs also increase adoption and usage, thereby driving the overall growth of the market.
• Increasing Awareness and Screening Programs: This growth is facilitated by increasing awareness regarding breast cancer and expanding screening programs, which encourage the utilization of advanced imaging technologies. Public health advertisements and a greater focus on early diagnosis are key in promoting the uptake of CEDM.
• Rising Healthcare Spending: The demand for advanced imaging technologies is fueled by growing expenditure on women’s health, particularly breast cancer diagnostics. Higher spending on diagnostic tools helps in establishing CEDM systems.
Challenges in the contrast-enhanced digital mammography market include:
• High Cost of Advanced Systems: A major challenge posed by the high costs of CEDM systems particularly affects healthcare systems with low budgets. Accessibility and adoption rates can be impacted by expensive technology, highlighting the need for affordable alternatives and funding strategies.
• Regulatory and Compliance Issues: Navigating through regulatory and compliance issues can take a long time. Market entry may be delayed, and development timelines altered due to the need to comply with different standards or obtain approval for new CEDM technologies.
• Limited Access in Remote Areas: Limited access to advanced imaging technologies in remote and underserved areas presents a significant challenge. To address this, investment in portable solutions and expanding outreach efforts are necessary to cover more CEDM users.
There are several developments in the CEDM market driven by technological advancements and increased awareness. Despite such growth, however, various challenges must be resolved, including high costs and regulatory issues. It is important that these factors are managed properly to optimize market potential and enhance breast cancer detection and management.
List of Contrast Enhanced Digital Mammography Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies contrast enhanced digital mammography companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the contrast enhanced digital mammography companies profiled in this report include-
• Ge Healthcare
• Siemens Healthineers
• Allengers Medical Systems
• Planmed Oy
• Hologic
Contrast Enhanced Digital Mammography by Segment
The study includes a forecast for the global contrast enhanced digital mammography by technique, application, end use, and region.
Contrast Enhanced Digital Mammography Market by Technique [Analysis by Value from 2018 to 2030]:
• Temporal Subtraction
• Dual Energy CEDM
Contrast Enhanced Digital Mammography Market by Application [Analysis by Value from 2018 to 2030]:
• Screening
• Diagnosis
Contrast Enhanced Digital Mammography Market by End Use [Analysis by Value from 2018 to 2030]:
• Hospital
• Diagnostic Centers
• Specialty Clinics
• Others
Contrast Enhanced Digital Mammography Market by Region [Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
Country Wise Outlook for the Contrast Enhanced Digital Mammography Market
The digital world is changing every day, and one of the many changes observed in the last few years is the advent of contrast-enhanced digital mammography (CEDM). This article focuses on some recent developments in key countries.
• United States: In contrast, enhanced digital mammography (CEDM) is becoming well-known in the US as more healthcare providers realize its advantages over conventional mammograms. The growth of CEDM has been driven by its capability to enhance tumor detection, particularly among women with dense breast tissue. Some new technological advancements include the integration of AI tools to improve image analysis and minimize false positives. Major medical centers have acquired CEDM technology, facilitated by supportive regulatory approvals and increased demand for accurate diagnostic devices. Furthermore, ongoing research and clinical trials indicate that CEDM is effective.
• China: China is quickly embracing CEDM technology as part of its drive to modernize breast cancer screening and diagnosis. Advanced CEDM systems are being introduced, particularly for small, early tumors. Subsidies and health reforms aimed at improving early detection are helping the government expand technologies in breast imaging. Public-private partnerships with overseas companies have enabled the deployment of state-of-the-art CEDM devices in both urban and rural areas, thereby providing more comprehensive solutions to address the issue of breast cancer screening.
• Germany: Germany stands at the forefront of the adoption and integration of contrast-enhanced digital mammography (CEDM) into everyday healthcare. There has been an increase in German precision medicine that has driven this change towards better tumor detection and characterization through increased use of CEDM. Cutting-edge CEDM systems are being acquired by hospitals across Germany due to a strong healthcare infrastructure and funding for technological advancements. German research institutions also engage in investigations on how effective CEDM can be, which has led to wider adoption within their healthcare systems.
• India: The integration of contrast-enhanced digital mammography (CEDM) into IndiaÄX%$%Xs breast cancer screening process is being adopted to intensify the fight against this disease. Advancements have been made in major towns with the availability of CEDM equipment and training programs for radiologists. These efforts by the Indian government support the adoption of CEDM as part of its strategies to improve cancer screening programs and increase public awareness. Partnerships with international vendors and affordable options will serve as effective tools for broadening access to advanced technologies in breast imaging, aimed at addressing the rising need for accurate diagnostic devices.
• Japan: To enhance its breast cancer screening procedures, Japan has adopted contrast-enhanced digital mammography (CEDM). The transition to CEDM as a component of its screening program is backed by Japan’s commitment to quality healthcare and technological progress. Recent developments include the introduction of high-resolution CEDM systems and AI-enhanced image analysis tools. Supported by Japanese authorities focused on the growth of modern diagnostic technologies and ongoing research on the benefits of early detection and diagnostic accuracy, medical providers are now targeting the expansion of CEDM applications across both urban and rural areas in Japan.
Features of the Global Contrast Enhanced Digital Mammography Market
Market Size Estimates: Contrast enhanced digital mammography market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Contrast enhanced digital mammography market size by technique, application, end use, and region in terms of value ($B).
Regional Analysis: Contrast enhanced digital mammography market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different techniques, applications, end uses, and regions for the contrast enhanced digital mammography market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the contrast enhanced digital mammography market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.
FAQ
Q.1 What is the contrast enhanced digital mammography market size?
Answer: The global contrast enhanced digital mammography market is expected to reach an estimated $0.8 billion by 2030.
Q.2 What is the growth forecast for contrast enhanced digital mammography market?
Answer: The global contrast enhanced digital mammography market is expected to grow with a CAGR of 10.6% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the contrast enhanced digital mammography market?
Answer: The major drivers for this market are rising cases of breast cancer, increasing awareness about breast cancer, and introduction of software in mammography equipment.
Q4. What are the major segments for contrast enhanced digital mammography market?
Answer: The future of the contrast enhanced digital mammography market looks promising with opportunities in the screening and diagnosis markets.
Q5. Who are the key Contrast Enhanced Digital Mammography Market companies?
Answer: Some of the key contrast enhanced digital mammography companies are as follows:
• GE Healthcare
• Siemens Healthineers
• Allengers Medical Systems
• Planmed OY
• Hologic
Q6. Which contrast enhanced digital mammography market segment will be the largest in future?
Answer: Lucintel forecasts that dual energy CEDM will remain the largest segment over the forecast period as it helps in detecting the early stage of breast cancer.
Q7. In contrast enhanced digital mammography market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to high prevalence of breast cancer and wide base of medical device companies in the U.S.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the contrast enhanced digital mammography market by technique (temporal subtraction and dual energy CEDM), application (screening and diagnosis), end use (hospital, diagnostic centers, specialty clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Contrast Enhanced Digital Mammography Market, Contrast Enhanced Digital Mammography Market Size, Contrast Enhanced Digital Mammography Market Growth, Contrast Enhanced Digital Mammography Market Analysis, Contrast Enhanced Digital Mammography Market Report, Contrast Enhanced Digital Mammography Market Share, Contrast Enhanced Digital Mammography Market Trends, Contrast Enhanced Digital Mammography Market Forecast, Contrast Enhanced Digital Mammography Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.